Atlas Trials

Imunon

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Imunon

RecordFirmDate
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer (NCT06915025)Imunon2025-07-09
Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 (NCT06283459)Imunon2024-06-04
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05739981)Imunon2023-02-10
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) (NCT03393884)Imunon2018-09-05

Track Imunon automatically

Every clearance here is in the API, with alerts when new ones post.